Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-60
SponsorLiverpool John Moores University

About this trial

The goal of this clinical trial is to learn whether following a Mediterranean-style diet or a Carnivore-style diet can improve heart and metabolic health in men and women aged 30-60 years with high LDL cholesterol.

The main questions it aims to answer are:

1. Does following a Mediterranean or Carnivore diet change how easily LDL cholesterol particles clump together (LDL aggregation susceptibility)? 2. Do these two diets have different effects on other measures of heart and metabolic health, such as blood fats, blood vessel function, and overall wellbeing?

Researchers will compare people who follow the Mediterranean-style diet with those who follow the Carnivore-style diet to see which diet produces more beneficial changes in cholesterol and heart health markers.

Participants will:

* Attend three visits at Liverpool John Moores University for screening and data collection. * Be randomly assigned to follow either the Mediterranean or Carnivore diet for 3 weeks, matched for calories and protein. * Provide fasting blood, urine, and stool samples before and after the diet period. * Complete non-invasive cardiovascular tests to measure blood vessel and heart function. * Take part in a short interview and complete questionnaires about their experience of following the diet.

Eligibility criteria

Qualifiers

Male or female

30-60 years of age

Elevated LDL cholesterol (LDL >3mmol/L and/or non-HDL cholesterol > 4mmol/L)

Not following any specific diet for health reasons.

Disqualifiers

Pregnancy or breastfeeding.

Known food allergies or intolerances.

Previous history of disordered eating.

Currently taking cholesterol-lowering medication or supplements.

Trial design

Treatments tested in this trial

  • Carnivore Diet
  • Mediterranean Diet

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Liverpool John Moores University

Lead sponsor

Wihuri Research Institute

Collaborator

University of Helsinki

Collaborator